The FTSE 100 offers great near-term valuations and dividend yields, but Dr James Fox believes investors should be wary when ...

Markets on Wall Street inched modestly lower before the opening bell on Monday as they kicked off the final month of 2024 ...

Suraksha Diagnostic IPO subscription status was 11% on the first bidding day. The initial share sale, valued at ₹846 crore, ...

Federal prosecutors have broadened a criminal investigation to determine whether Archer-Daniels-Midland deliberately misled ...

The CEO’s exit comes after the automaker reported a slump in sales and slashed its profit outlook earlier for this year.

While the artificial intelligence (AI) revolution has been undeniably important in lifting the broader market, it would be ...

Lloyds shares and other banking stocks have thrived in 2024, but has it been a good investment for shareholders who invested ...

Thailand looks to resume direct flights to the U.S. early next year, as it anticipates an upgrade to a Category 1 safety ...

Argo's Chief Executive Officer, Thomas Chippas, commented, "This subscription strengthens our balance sheet, moving Argo closer to execution of the HPC opportunity at Baie-Comeau and Helios fleet ...

MicroStrategy Inc. MSTR Chairman Michael Saylor pitched a strong case for Bitcoin BTC/USD adoption to the Microsoft Corp. MSFT board, projecting a $5 trillion market cap addition in case of a full ...

We recently published a list of 10 Best Affordable Tech Stocks To Invest In Now. In this article, we are going to take a look ...

Libra Infusions Limited published its three-quarters financial statement from the July to March period of FY22, whereas the company posted impressive profit growth compared to the previous FY.